qordata
  • Products
    • Reporting
    • Transparency Reporting Solution
    • Monitoring
    • Compliance Central
    • Expense Monitoring & Auditing Solution (EMA)
    • Process
    • EngageAgent
    • Grants & Sponsorship Management Solution
  • Thought Leadership
    • Surveys and Insights
    • Whitepapers
    • Case Studies
    • Webinars
    • Blogs
  • Company
    • About Us
    • Leadership Team
    • Our Partners
    • Contact Us
(609) 375-0010
Request a Demo
Reporting Transparency Reporting Solution Monitoring Compliance Central Expense Monitoring & Auditing Solution (EMA) Process EngageAgent Grants & Sponsorship Management Solution
Surveys and Insights Whitepapers Case Studies Webinars Blogs
About Us Leadership Team Our Partners Contact Us
(609) 375-0010 Request a Demo
Cookie Preferences We use cookies We use cookies to enhance your browsing experience, personalise content, and analyse traffic. You can accept all cookies or manage your preferences.
Cookie Preferences

Manage your preferences

Choose which categories of cookies you're comfortable with. You can change this anytime by revisiting this banner.

Necessary Required for the site to run. Cannot be turned off.
Always Active
Analytics Helps us understand how visitors use the site.
Marketing Used to personalise content and measure campaign performance.
PhRMA code update and its implications | qordata
On-Demand Webinar

PhRMA code update and its implications

On-Demand Webinar · Jun 28, 2024
✓On-Demand Access
✓Expert Industry Speakers
✓Actionable Key Takeaways
✓Free to Watch

About the Webinar

On August 6, 2021, the Pharmaceutical Research and Manufacturers of America (PhRMA) released highly anticipated revisions to its Code on Interactions with Health Care Professionals, which becomes effective on January 1, 2022. This webinar will examine key changes to the following PhRMA Code sections and their practical implications:

  • Section 2 - Informational Presentations by Company Representatives - with attention to incidental meals
  • Section 5 - Third Party Educational or Professional Meetings - discussing virtual events and interactions
  • Section 6 - Consulting Arrangements - regarding consultant selection, meals, and meeting venues
  • Changes to Section 7 - Speaker Programs - with focus on meals, alcohol, and speaker selection

Key Takeaways

  • Benchmarking regarding how other companies plan to address the PhRMA Code changes
  • New enforcement risks raised at the federal and state levels
  • Suggestions regarding Compliance Program and policy updates that may be required by the Code changes
  • Auditing and monitoring measures to drive compliance with the revised Code

Meet Our Expert Speakers

Seth H. Lundy

Deputy chair of the King & Spalding FDA & Life Sciences Practice Group

Brian A. Bohnenkamp

Partner at King & Spalding

All Webinars

Watch On Demand

About the Webinar: On August 6, 2021, the Pharmaceutical Research and Manufacturers of America (PhRMA) released highly anticipated revisions

Need help? info@qordata.com

Put phrma code update into practice

Talk to our team about applying what you learned to your own compliance program.

Request a Demo

Frequently Asked Questions

What does the “PhRMA code update and its implications” webinar cover?

On August 6, 2021, the Pharmaceutical Research and Manufacturers of America (PhRMA) released highly anticipated revisions to its Code on Interactions with Health Care Professionals, which becomes effective on January 1, 2022. This webinar will examine key changes to the following PhRMA Code sections and their practical implications: Section 2 - Informational Presentations by Company Representatives - with attention to incidental meals Section 5 - Third Party Educational or Professional Meetings - discussing virtual events and interactions Section 6 - Consulting Arrangements - regarding consultant selection, meals, and meeting venues Changes to Section 7 - Speaker Programs - with focus on meals, alcohol, and speaker selection

Who presented this webinar?

This on-demand session features Seth H. Lundy (Deputy chair of the King & Spalding FDA & Life Sciences Practice Group) and Brian A. Bohnenkamp (Partner at King & Spalding).

What will I take away from this session?

Key takeaways include: Benchmarking regarding how other companies plan to address the PhRMA Code changes; New enforcement risks raised at the federal and state levels; Suggestions regarding Compliance Program and policy updates that may be required by the Code changes; Auditing and monitoring measures to drive compliance with the revised Code.

0
Skip to Content
qordata
qordata
qordata — data driven compliance
(609) 375-0010 103 Carnegie Center Drive, Suite 300, Princeton, NJ 08540
Products
  • Transparency Reporting Solution
  • Compliance Central
  • Expense Monitoring & Auditing (EMA)
  • EngageAgent
  • Grants & Sponsorship Management
Thought Leadership
  • Surveys and Insights
  • Whitepapers
  • Case Studies
  • Webinars
  • Blogs
Company
  • About Us
  • Leadership Team
  • Our Partners
  • Contact Us
  • Careers
© qordata 2026. All rights reserved.
Privacy Policy Terms of Use Sitemap Cookie Preferences